Stereotaxis (STXS) Other Non-Current Assets (2010 - 2026)
Stereotaxis' (STXS) quarterly Other Non-Current Assets came in at $330000.0 in Q1 2026, up 230.0% year-over-year from $100000.0 in Q1 2025, and up 18.71% quarter-over-quarter from $278000.0 in Q4 2025.
Powered by 
Analysis
Stereotaxis (STXS) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Other Non-Current Assets for 17 consecutive years, with $330000.0 the latest figure, recorded in Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 230.0% year-over-year to $330000.0 in Q1 2026; TTM through Mar 2026 was $330000.0, a 230.0% increase from a year earlier, with the FY2025 full-year figure at $278000.0, up 159.81% from the prior year.
- Other Non-Current Assets was $330000.0 for Q1 2026 at Stereotaxis, up from $278000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $1.3 million in Q4 2022 and troughed at $100000.0 in Q1 2025.
- A 5-year average of $511411.8 and a median of $400000.0 in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets soared 1123.66% in 2022 and tumbled 83.33% in 2025, its largest moves.
- Over 5 years, Other Non-Current Assets stood at $1.3 million in 2022, then sank by 83.15% to $219000.0 in 2023, then plunged by 51.14% to $107000.0 in 2024, then surged by 159.81% to $278000.0 in 2025, then advanced by 18.71% to $330000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $330000.0 (Q1 2026), $278000.0 (Q4 2025), and $280000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 4.32 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 3.23 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 616.40 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 434.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 273.70 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn | 330,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 330,000.00 |
| Dec 31, 2025 | 278,000.00 |
| Sep 30, 2025 | 280,000.00 |
| Jun 30, 2025 | 118,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 107,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Dec 31, 2023 | 219,000.00 |
| Sep 30, 2023 | 350,000.00 |
| Jun 30, 2023 | 481,000.00 |
| Mar 31, 2023 | 612,000.00 |
| Dec 31, 2022 | 1.30 Mn |
| Sep 30, 2022 | 875,000.00 |
| Jun 30, 2022 | 1.01 Mn |
| Mar 31, 2022 | 1.14 Mn |
| Dec 31, 2021 | 952,000.00 |
| Sep 30, 2021 | 700,000.00 |
| Jun 30, 2021 | 383,000.00 |